Skip to main content

Karyopharm Therapeutics Inc 10-Q for FY2024 Q3

Karyopharm Therapeutics Inc. (KPTI)

10-Q 2024-11-05 For: 2024-09-30
View Original
Added on April 12, 2026

About this 10-Q

Karyopharm Therapeutics Inc filed this 10-Q on November 5, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$38.78M
up 7.7% from $36.01M a year earlier
Net loss
$32.07M
compared with a net loss of $34.51M a year earlier
Diluted EPS
-$0.26
compared with -$0.30 a year earlier